Table 1 Overall seropositivity percentage in the cohort and spearman correlation between the different tests performed.
From: Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis
E_rK39 | E_LicTXNPX | E_LAM | E_SPLA | E_Comercial | IFAT 1 | IFAT 2 | IFAT 3 | ||
|---|---|---|---|---|---|---|---|---|---|
Seropositivity (%) | 53.0 | 42.2 | 56.6 | 48.2 | 49.4 | 57.8 | 45.8 | 51.8 | |
Spearman Correlation | E_rK39 | 1.00 | 0.83 | 0.94 | 0.91 | 0.79 | 0.67 | 0.74 | 0.80 |
E_LicTXNPX | 0.83 | 1.00 | 0.84 | 0.84 | 0.75 | 0.60 | 0.64 | 0.69 | |
E_LAM | 0.94 | 0.84 | 1.00 | 0.87 | 0.77 | 0.69 | 0.75 | 0.78 | |
E_SPLA | 0.91 | 0.84 | 0.87 | 1.00 | 0.83 | 0.72 | 0.73 | 0.76 | |
E_Comercial | 0.79 | 0.75 | 0.77 | 0.83 | 1.00 | 0.69 | 0.78 | 0.78 | |
IFAT 1 | 0.67 | 0.60 | 0.69 | 0.72 | 0.69 | 1.00 | 0.69 | 0.74 | |
IFAT-2 | 0.74 | 0.64 | 0.75 | 0.73 | 0.78 | 0.69 | 1.00 | 0.79 | |
IFAT-3 | 0.80 | 0.69 | 0.78 | 0.76 | 0.78 | 0.74 | 0.79 | 1.00 | |
